Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Atezolizumab + tiragolumab) by F. Hoffmann-La Roche for Solid Tumor: Likelihood of Approval
(Atezolizumab + tiragolumab) is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Solid Tumor. According...